Investigational drug · Phase 2
NCS-01
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Ischemic Stroke.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 11, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "NCS-01"
First trial start
2020
Feb 27, 2020
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "NCS-01", any sponsor or status.
Conditions studied
As listed on its trial records.
- Ischemic Stroke
Approved drugs for the same conditions: Stroke prevention · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "NCS-01" as an intervention, largest first.
- A Study of NCS-01 in Patients With Acute Ischemic StrokeActive, not recruiting
NC Medial Research IncIndustry
NCT03915431 · 16 participants (planned) · Start Feb 27, 2020 · Primary completion Oct 2027
Drug: NCS-01 · For: Ischemic Stroke
Sites: Miami, Florida
Newest research
PubMed records naming it or its code names, newest first.
- Bone marrow-derived NCS-01 cells for ischemic stroke.
Saft M, Koga M, Borlongan CV · Brain Circ 2021
- Bone Marrow-Derived NCS-01 Cells Advance a Novel Cell-Based Therapy for Stroke.
Brown J, Park YJ, Lee JY, et al. · Int J Mol Sci 2020
- Translating intracarotid artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy.
Kaneko Y, Lee JY, Tajiri N, et al. · Stem Cells Transl Med 2020
Also in development for Ischemic Stroke
- OtaplimastatSP-8203Phase 31 trial
Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke
- SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials
PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke
- Umbilical Cord Mesenchymal Stem CellsMesenchymal stromal cells, Allogeneic Mesenchymal Stem CellsPhase 24 trials
PT. Prodia Stem Cell Indonesia · Diabetic Nephropathy Type 2, Ischemic Stroke, Cerebral Palsy
- TS23Phase 22 trials
Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism
- TBO-309Phase 21 trial
ThromBio Pty. Ltd. · Ischemic Stroke, Tandem Occlusion
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.